Cuneyt Ozden
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cuneyt Ozden has a total of 158 co-authors. Here are the top co-authors by number of shared publications:
Ali Memis
Department of Urology, Numune Training and Research Hospital, Ankara, Turkey
26 shared publications- Binhan Kagan Aktas
Urology Clinic, Numune Training and Research Hospital, Ankara, Turkey
15 shared publications Suleyman Bulut
Department of Urology, Numune Training and Research Hospital, Ankara, Turkey
13 shared publications- Ozdem Levent Ozdal
Numune Education and Research Hospital
11 shared publications Cevdet Serkan Gokkaya
Ankara Numune Training & Res Hosp, Dept Urol, Ankara, Turkey
10 shared publications- Yalcin Kizilkan
Ankara Bilkent City Hospital
10 shared publications
Latest Publications
- 7 November 2026
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1) , 1179
Effect of positive surgical margin characteristics on biochemical failure following robot-assisted radical prostatectomy
- 7 November 2026
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1) , 1179
Effect of positive surgical margin characteristics on biochemical failure following robot-assisted radical prostatectomy
- Open Access
- 23 June 2026
- Published by Springer Nature in BMC Urology
- Vol. 26 (1)
Variant histology in urothelial carcinoma: associated factors and survival impact after radical cystectomy
Purpose: To investigate the factors associated with variant histology (VH) and prognostic significance of VH in urothelial carcinoma (UC) among patients undergoing radical cystectomy (RC) with ileal conduit urinary diversion. Methods: A retrospective analysis was conducted on 317 patients who underwent RC with ileal conduit diversion between 2019 and 2025. Patients were categorized based on the presence of VH in the final pathology. Demographic, clinical, perioperative, and pathological data were compared. Logistic regression was performed to identify factors associated with VH, while Kaplan–Meier and uni-multivariable Cox regression analyses evaluated overall survival (OS) and cancer-specific survival (CSS). Results: VH was detected in 139 patients (43.8%), with squamous differentiation being the most prevalent variant, observed in 80 patients of the 317 patients who underwent RC with ileal conduit urinary diversion. Presence of hydronephrosis, clinical lymph node positivity and WBC > 7695 g/dl were defined as factors associated with VH in multivariate logistic regression analysis. Kaplan–Meier survival analysis illustrated a statistically significant reduction in OS and CSS among patients harboring VH compared to those with pure UC following RC and ileal conduit urinary diversion (53.8 vs. 36.8 months for OS and 68 vs. 53 months for CSS, log-rank test, p < 0.001). Multivariable Cox regression analysis revealed that presence of variant histology was associated with reduced OS (HR = 1.624; 95% CI = 1.094–2.411; p = 0.016) and CSS (HR = 1.945; 95% CI = 1.043–3.626; p = 0.036). Conclusion: VH in UC is associated with advanced disease and poorer survival outcomes following RC. Certain preoperative factors—hydronephrosis, clinical lymphadenopathy, and elevated WBC—may be associated with the presence of VH. Early recognition of these features could guide individualized treatment strategies and improve prognostic assessment. However, the retrospective and single-center nature of this study may introduce selection and information bias, and the findings should be interpreted with caution until validated by prospective multicenter trials.
- 23 June 2026
- Published by Springer Nature in BMC Urology
- Vol. 26 (1)
Open AccessVariant histology in urothelial carcinoma: associated factors and survival impact after radical cystectomy
Purpose: To investigate the factors associated with variant histology (VH) and prognostic significance of VH in urothelial carcinoma (UC) among patients undergoing radical cystectomy (RC) with ileal conduit urinary diversion. Methods: A retrospective analysis was conducted on 317 patients who underwent RC with ileal conduit diversion between 2019 and 2025. Patients were categorized based on the presence of VH in the final pathology. Demographic, clinical, perioperative, and pathological data were compared. Logistic regression was performed to identify factors associated with VH, while Kaplan–Meier and uni-multivariable Cox regression analyses evaluated overall survival (OS) and cancer-specific survival (CSS). Results: VH was detected in 139 patients (43.8%), with squamous differentiation being the most prevalent variant, observed in 80 patients of the 317 patients who underwent RC with ileal conduit urinary diversion. Presence of hydronephrosis, clinical lymph node positivity and WBC > 7695 g/dl were defined as factors associated with VH in multivariate logistic regression analysis. Kaplan–Meier survival analysis illustrated a statistically significant reduction in OS and CSS among patients harboring VH compared to those with pure UC following RC and ileal conduit urinary diversion (53.8 vs. 36.8 months for OS and 68 vs. 53 months for CSS, log-rank test, p < 0.001). Multivariable Cox regression analysis revealed that presence of variant histology was associated with reduced OS (HR = 1.624; 95% CI = 1.094–2.411; p = 0.016) and CSS (HR = 1.945; 95% CI = 1.043–3.626; p = 0.036). Conclusion: VH in UC is associated with advanced disease and poorer survival outcomes following RC. Certain preoperative factors—hydronephrosis, clinical lymphadenopathy, and elevated WBC—may be associated with the presence of VH. Early recognition of these features could guide individualized treatment strategies and improve prognostic assessment. However, the retrospective and single-center nature of this study may introduce selection and information bias, and the findings should be interpreted with caution until validated by prospective multicenter trials.
- 24 March 2026
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1)
Predictors of persistent PSA after robot-assisted radical prostatectomy: a high-volume single-center experience
- 24 March 2026
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1)
Predictors of persistent PSA after robot-assisted radical prostatectomy: a high-volume single-center experience
- Open Access
- 28 February 2026
- Published by Pera Yayıncılık Hizmetleri in The New Journal of Urology
- Vol. 21 (1) , 39
Effects of Neoadjuvant Chemotherapy Treatment on Perioperative Outcomes Following Radical Cystectomy
Objective: This study aimed to assess the impact of neoadjuvant chemotherapy (NAC) on perioperative outcomes in patients undergoing radical cystectomy (RC) for urothelial carcinoma. Materials and Methods: We retrospectively analyzed the clinical records of 317 patients who underwent RC and ileal loop diversion between February 2019 and May 2025. Patients were categorized into NAC+RC and RC-only groups. Demographic, preoperative, intraoperative, and postoperative variables were evaluated. Propensity score matching (PSM) was conducted to match the groups in a 1:1 ratio using the nearest-neighbor matching algorithm in terms of age, body mass index (BMI), previous surgery history, American Society of Anesthesiologists (ASA) score, preoperative T stage, hemoglobin, white blood cell (WBC), incision length and urinary diversion technique. Results: Among the 317 patients, 60 (18.9%) received NAC+RC and 257 (81.1%) underwent RC alone. Preoperative T2 stage was more prevalent in the NAC group compared with the RConly group (85% vs. 68.5%, p=0.024). Preoperative hemoglobin (12.6 vs. 11.9 g/dL, p=0.006) and white blood cell levels (8886.9 vs. 7416.8/μL, p<0.001) were significantly higher in the RConly group. Postoperative complications were more frequent among RC-only patients (47.5% vs. 31.7%, p=0.027). After PSM, 57 matched pairs were obtained. The RC-only group demonstrated higher blood transfusion requirements (1 vs. 0 units, p = 0.048), longer hospitalization (17 vs. 15 days, p=0.015), and delayed return to oral intake (3 vs. 3 days, p=0.028) compared with the matched NAC+RC group. Although complications were more common in the RC-only group, the difference was not statistically significant (29% vs. 19%, p=0.058). Conclusion: NAC does not adversely affect perioperative morbidity following RC and may enhance specific postoperative recovery parameters. These findings support the safety and clinical value of NAC in appropriately selected patients with muscle-invasive bladder cancer. Keywords: complication, neoadjuvant chemotherapy, radical cystectomy, treatment
- 28 February 2026
- Published by Pera Yayıncılık Hizmetleri in The New Journal of Urology
- Vol. 21 (1) , 39
Open AccessEffects of Neoadjuvant Chemotherapy Treatment on Perioperative Outcomes Following Radical Cystectomy
Objective: This study aimed to assess the impact of neoadjuvant chemotherapy (NAC) on perioperative outcomes in patients undergoing radical cystectomy (RC) for urothelial carcinoma. Materials and Methods: We retrospectively analyzed the clinical records of 317 patients who underwent RC and ileal loop diversion between February 2019 and May 2025. Patients were categorized into NAC+RC and RC-only groups. Demographic, preoperative, intraoperative, and postoperative variables were evaluated. Propensity score matching (PSM) was conducted to match the groups in a 1:1 ratio using the nearest-neighbor matching algorithm in terms of age, body mass index (BMI), previous surgery history, American Society of Anesthesiologists (ASA) score, preoperative T stage, hemoglobin, white blood cell (WBC), incision length and urinary diversion technique. Results: Among the 317 patients, 60 (18.9%) received NAC+RC and 257 (81.1%) underwent RC alone. Preoperative T2 stage was more prevalent in the NAC group compared with the RConly group (85% vs. 68.5%, p=0.024). Preoperative hemoglobin (12.6 vs. 11.9 g/dL, p=0.006) and white blood cell levels (8886.9 vs. 7416.8/μL, p<0.001) were significantly higher in the RConly group. Postoperative complications were more frequent among RC-only patients (47.5% vs. 31.7%, p=0.027). After PSM, 57 matched pairs were obtained. The RC-only group demonstrated higher blood transfusion requirements (1 vs. 0 units, p = 0.048), longer hospitalization (17 vs. 15 days, p=0.015), and delayed return to oral intake (3 vs. 3 days, p=0.028) compared with the matched NAC+RC group. Although complications were more common in the RC-only group, the difference was not statistically significant (29% vs. 19%, p=0.058). Conclusion: NAC does not adversely affect perioperative morbidity following RC and may enhance specific postoperative recovery parameters. These findings support the safety and clinical value of NAC in appropriately selected patients with muscle-invasive bladder cancer. Keywords: complication, neoadjuvant chemotherapy, radical cystectomy, treatment
- Open Access
- 14 March 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (11) , e41742
The relationship between serum Endocan and ADMA levels and penile Doppler ultrasonography findings in patients with severe erectile dysfunction
To evaluate the relationship between serum endothelial cell specific molecule-1 (Endocan), asymmetric dimethylarginine (ADMA) values, and penile Doppler ultrasonography (USG) findings in patients with severe erectile dysfunction (ED). This prospective study included 73 patients who were classified as severe ED and had an indication for penile Doppler USG in our urology outpatient clinic between April 2017 and January 2020. Fasting blood sugar, lipid profile, thyroid function tests, total testosterone, and serum Endocan and ADMA values were sampled, and penile Doppler USG examination data were recorded. Vasculogenic ED was detected in 51 (69.86%) of 73 patients, while the flow rates were normal in 22 (30.14%). Among those with vasculogenic ED, 15 (29.41%) had arterial insufficiency, 22 (43.13%) had venous leakage, and 14 (27.46%) had mixed. There was no statistically significant difference between the mean ADMA and Endocan values of ED with normal flow (14.44 ± 6.20 ng/mL and 0.18 ± 0.14 ng/mL) and the vasculogenic ED (12.31 ± 5.86 ng/mL and 0.21 ± 0.16 ng/mL) groups ( P = .097 for ADMA and P = .315 for Endocan, respectively). Endocan and ADMA levels were not predictors of severe ED. There is a need for multicenter studies with larger patient populations to be conducted with different biomarkers that may have a higher predictive value in the future.
- 14 March 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (11) , e41742
Open AccessThe relationship between serum Endocan and ADMA levels and penile Doppler ultrasonography findings in patients with severe erectile dysfunction
To evaluate the relationship between serum endothelial cell specific molecule-1 (Endocan), asymmetric dimethylarginine (ADMA) values, and penile Doppler ultrasonography (USG) findings in patients with severe erectile dysfunction (ED). This prospective study included 73 patients who were classified as severe ED and had an indication for penile Doppler USG in our urology outpatient clinic between April 2017 and January 2020. Fasting blood sugar, lipid profile, thyroid function tests, total testosterone, and serum Endocan and ADMA values were sampled, and penile Doppler USG examination data were recorded. Vasculogenic ED was detected in 51 (69.86%) of 73 patients, while the flow rates were normal in 22 (30.14%). Among those with vasculogenic ED, 15 (29.41%) had arterial insufficiency, 22 (43.13%) had venous leakage, and 14 (27.46%) had mixed. There was no statistically significant difference between the mean ADMA and Endocan values of ED with normal flow (14.44 ± 6.20 ng/mL and 0.18 ± 0.14 ng/mL) and the vasculogenic ED (12.31 ± 5.86 ng/mL and 0.21 ± 0.16 ng/mL) groups ( P = .097 for ADMA and P = .315 for Endocan, respectively). Endocan and ADMA levels were not predictors of severe ED. There is a need for multicenter studies with larger patient populations to be conducted with different biomarkers that may have a higher predictive value in the future.
- Open Access
- 30 October 2024
- Published by Pera Yayıncılık Hizmetleri in The New Journal of Urology
- Vol. 19 (3) , 145-150
Outcomes of Emergency Surgical Treatment for Penile Fractures: A Study on Suture Materials, Delayed Repair, and Postoperative Results
Objective: This study examines the impact of surgical timing and suture materials on postoperative outcomes in penile fracture patients, particularly focusing on the development of penile curvature (PC). Materials and Methods: A retrospective analysis was conducted on 63 patients treated for penile fractures between 2015 and 2024. Data on the time to surgery, suture materials, and postoperative complications such as PC were collected. Results: PC occurred in 27% of patients, with a significantly longer surgical delay in those with PC compared to those without. Suture material type (2-0 Prolene vs. 3-0 Vicryl) had no significant effect on PC or nodule formation. Conclusion: Delayed surgical intervention is associated with an increased risk of PC. Early surgery is recommended to reduce complications, while suture material does not influence outcomes.
- 30 October 2024
- Published by Pera Yayıncılık Hizmetleri in The New Journal of Urology
- Vol. 19 (3) , 145-150
Open AccessOutcomes of Emergency Surgical Treatment for Penile Fractures: A Study on Suture Materials, Delayed Repair, and Postoperative Results
Objective: This study examines the impact of surgical timing and suture materials on postoperative outcomes in penile fracture patients, particularly focusing on the development of penile curvature (PC). Materials and Methods: A retrospective analysis was conducted on 63 patients treated for penile fractures between 2015 and 2024. Data on the time to surgery, suture materials, and postoperative complications such as PC were collected. Results: PC occurred in 27% of patients, with a significantly longer surgical delay in those with PC compared to those without. Suture material type (2-0 Prolene vs. 3-0 Vicryl) had no significant effect on PC or nodule formation. Conclusion: Delayed surgical intervention is associated with an increased risk of PC. Early surgery is recommended to reduce complications, while suture material does not influence outcomes.
- 28 February 2024
- Published by Springer Nature in Urolithiasis
- Vol. 52 (1) , 1-8
The fate of clinically insignificant residual fragments following retrograde intrarenal surgery and factors affecting spontaneous passage
The remaining stone fragments after retrograde intrarenal surgery (RIRS) can lead to stone recurrence/regrowth, or stone-related events (SRE). We aimed to delineate the clinical circumstances that are decisive for spontaneous passage of clinical insignificant residual fragments (CIRF) (primary outcome) and define risk factors for stone recurrence/regrowth and their clinical manifestation (secondary outcome). A total of 115 patients who had CIRF following RIRS were included in this study. Demographic, clinical data, stone, and anatomic characteristics including infundibulopelvic angle (IPA), infundibular length (IL) and follow-up data of patients were analyzed. The mean follow-up time was 27.5 ± 6.9 months. 31 (26.9%) patients passed the CIRF spontaneously. Patients were divided into two groups as spontaneous fragment passage group and fragment remaining group and compared with respect to demographic, clinical, stone-related, and anatomic characteristics. 61.2% of patients had lower pole CIRF in fragment remaining group and 83.3% of patients in spontaneous fragment passage group (p = 0.031). In addition, IPA was wider in spontaneous fragment passage group (60.7° vs 51.4°, p = 0.001). A subanalysis was performed for fragment remaining group. In 84 patients, 44 (52.4%) patients were stable for their CIRF at their follow-up and included in stable group. 40 (47.6%) patients experienced stone re-growth (27 patients) or SRE (13 patients) at their follow up. Patients in re-growth/SRE group were older (49.1 vs 39.4 years, p = 0.047), had higher body mass index (28.2 vs 27 kg/m2, p = 0.03) and larger CIRF (2.8 vs 2.1 mm). CIRFs may be not expelled spontaneously and they may lead to additional morbidity and lithotripsy interventions.
- 28 February 2024
- Published by Springer Nature in Urolithiasis
- Vol. 52 (1) , 1-8
The fate of clinically insignificant residual fragments following retrograde intrarenal surgery and factors affecting spontaneous passage
The remaining stone fragments after retrograde intrarenal surgery (RIRS) can lead to stone recurrence/regrowth, or stone-related events (SRE). We aimed to delineate the clinical circumstances that are decisive for spontaneous passage of clinical insignificant residual fragments (CIRF) (primary outcome) and define risk factors for stone recurrence/regrowth and their clinical manifestation (secondary outcome). A total of 115 patients who had CIRF following RIRS were included in this study. Demographic, clinical data, stone, and anatomic characteristics including infundibulopelvic angle (IPA), infundibular length (IL) and follow-up data of patients were analyzed. The mean follow-up time was 27.5 ± 6.9 months. 31 (26.9%) patients passed the CIRF spontaneously. Patients were divided into two groups as spontaneous fragment passage group and fragment remaining group and compared with respect to demographic, clinical, stone-related, and anatomic characteristics. 61.2% of patients had lower pole CIRF in fragment remaining group and 83.3% of patients in spontaneous fragment passage group (p = 0.031). In addition, IPA was wider in spontaneous fragment passage group (60.7° vs 51.4°, p = 0.001). A subanalysis was performed for fragment remaining group. In 84 patients, 44 (52.4%) patients were stable for their CIRF at their follow-up and included in stable group. 40 (47.6%) patients experienced stone re-growth (27 patients) or SRE (13 patients) at their follow up. Patients in re-growth/SRE group were older (49.1 vs 39.4 years, p = 0.047), had higher body mass index (28.2 vs 27 kg/m2, p = 0.03) and larger CIRF (2.8 vs 2.1 mm). CIRFs may be not expelled spontaneously and they may lead to additional morbidity and lithotripsy interventions.
- 10 October 2022
- Published by Springer Nature in Urolithiasis
- Vol. 50 (6) , 765-771
Does surgical position affect infective complications in percutaneous nephrolithotomy?
- 10 October 2022
- Published by Springer Nature in Urolithiasis
- Vol. 50 (6) , 765-771
Does surgical position affect infective complications in percutaneous nephrolithotomy?
- Open Access
- 24 April 2022
- Published by Springer Nature in BMC Urology
- Vol. 22 (1) , 1-6
External validation of the T.O.HO. score as predictor of success after retrograde intrarenal surgery
Background: To assess the effectiveness of T.O.HO. (Tallness, Occupied lesion, Houndsfield unit evaluation) score in predicting the retrograde intrarenal surgery (RIRS) success and to validate this scoring system. Methods: The age, sex, previous stone surgery, hospitalization, surgery duration, postoperative complication, stone length, stone location, stone density, stone number, lateralization, presence of hydronephrosis, and presence of preoperative stent datas of 611 patients who underwent RIRS in our clinic between January 2013 and January 2021 were retrospectively assessed. The patients were divided into two groups as successful and unsuccessful. The T.O.HO scores of all patients were calculated. Results: The success rate was 72.5%. Compared to the unsuccessful group, stone length and stone density were lower, surgery duration was shorter and there were less lower pole stones in the successful group (p < 0.001). No significant difference was found between the two groups in terms of the other parameters. The T.O.HO. score was significantly lower in the successful group compared to the unsuccessful group (p < 0.001). According to the multivariate logistic regression analysis, stone length (OR: 0.905; 95% Cl: 0.866–0.946; p < 0.001), lower pole location (OR: 0.546; 95% Cl: 0.013–0.296; p < 0.001), stone density (OR: 0.999; 95% Cl: 0.998–1; p = 0.044) and the T.O.HO. score (OR: 0.684; 95%Cl: 0.554–0.844; p < 0.001) were found as the independent risk factors for RIRS success. ROC curve analysis showed that the T.O.HO. score could predict the RIRS success with 7.5 cut-off point (AUC: 0.799, CI: 0.76–0.839; p < 0.001). Conclusion: The T.O.HO. score can predict RIRS success with a high rate of accuracy.
- 24 April 2022
- Published by Springer Nature in BMC Urology
- Vol. 22 (1) , 1-6
Open AccessExternal validation of the T.O.HO. score as predictor of success after retrograde intrarenal surgery
Background: To assess the effectiveness of T.O.HO. (Tallness, Occupied lesion, Houndsfield unit evaluation) score in predicting the retrograde intrarenal surgery (RIRS) success and to validate this scoring system. Methods: The age, sex, previous stone surgery, hospitalization, surgery duration, postoperative complication, stone length, stone location, stone density, stone number, lateralization, presence of hydronephrosis, and presence of preoperative stent datas of 611 patients who underwent RIRS in our clinic between January 2013 and January 2021 were retrospectively assessed. The patients were divided into two groups as successful and unsuccessful. The T.O.HO scores of all patients were calculated. Results: The success rate was 72.5%. Compared to the unsuccessful group, stone length and stone density were lower, surgery duration was shorter and there were less lower pole stones in the successful group (p < 0.001). No significant difference was found between the two groups in terms of the other parameters. The T.O.HO. score was significantly lower in the successful group compared to the unsuccessful group (p < 0.001). According to the multivariate logistic regression analysis, stone length (OR: 0.905; 95% Cl: 0.866–0.946; p < 0.001), lower pole location (OR: 0.546; 95% Cl: 0.013–0.296; p < 0.001), stone density (OR: 0.999; 95% Cl: 0.998–1; p = 0.044) and the T.O.HO. score (OR: 0.684; 95%Cl: 0.554–0.844; p < 0.001) were found as the independent risk factors for RIRS success. ROC curve analysis showed that the T.O.HO. score could predict the RIRS success with 7.5 cut-off point (AUC: 0.799, CI: 0.76–0.839; p < 0.001). Conclusion: The T.O.HO. score can predict RIRS success with a high rate of accuracy.
- 22 October 2021
- Published by Pera Yayıncılık Hizmetleri in Yeni Üroloji Dergisi
- Vol. 16 (3) , 254-261
The relationship between the CAPRA-S and the time of biochemical recurrence following radical prostatectomy
Objective: In this study, we aimed to evaluate the relationship between biochemical recurrence time and the “cancer of the prostate risk assessment post-surgery” score (CAPRA-S) after radical prostatectomy (RP). Material and Methods: Retrospective evaluation was made of the records of 328 patients applied with RP for a diagnosis of clinically localized prostate cancer. The patients were separated into groups according to the CAPRA-S score determined according to the preoperative PSA level and pathological characteristics of the RP specimen and the biochemical recurrence time after RP. Results: The mean follow-up period was 76.9±34.5 months. Biochemical recurrence was determined in 23.2% (n:69) of the cases, as early recurrence in 71% (n:49) and late in 29% (n:20). According to the CAPRA-S score, 186 (62.4%) patients were classified as low risk, 66 (22.1%) as moderate risk, and 46 (15%) as high risk. The 3 and 5-year BRFS rates of all the patients were 88.9% and 81.8% respectively. Patients with a low CAPRA-S score were determined to have a statistically significantly higher 3 and 5-year BRFS rate than patients in the moderate and high groups. Early biochemical recurrence after RP was statistically significantly correlated only with lymph node involvement (OR: 2.42, 95% CI: 1.07-5.47, p=0.03). Conclusion: This study showed that the CAPRA-S score, which is effective in predicting the risk of biochemical recurrence after RP, was not effective in predicting the time of biochemical recurrence after RP. Keywords: Biochemical recurrence, CAPRA-S score, prostate cancer, radical prostatectomy
- 22 October 2021
- Published by Pera Yayıncılık Hizmetleri in Yeni Üroloji Dergisi
- Vol. 16 (3) , 254-261
The relationship between the CAPRA-S and the time of biochemical recurrence following radical prostatectomy
Objective: In this study, we aimed to evaluate the relationship between biochemical recurrence time and the “cancer of the prostate risk assessment post-surgery” score (CAPRA-S) after radical prostatectomy (RP). Material and Methods: Retrospective evaluation was made of the records of 328 patients applied with RP for a diagnosis of clinically localized prostate cancer. The patients were separated into groups according to the CAPRA-S score determined according to the preoperative PSA level and pathological characteristics of the RP specimen and the biochemical recurrence time after RP. Results: The mean follow-up period was 76.9±34.5 months. Biochemical recurrence was determined in 23.2% (n:69) of the cases, as early recurrence in 71% (n:49) and late in 29% (n:20). According to the CAPRA-S score, 186 (62.4%) patients were classified as low risk, 66 (22.1%) as moderate risk, and 46 (15%) as high risk. The 3 and 5-year BRFS rates of all the patients were 88.9% and 81.8% respectively. Patients with a low CAPRA-S score were determined to have a statistically significantly higher 3 and 5-year BRFS rate than patients in the moderate and high groups. Early biochemical recurrence after RP was statistically significantly correlated only with lymph node involvement (OR: 2.42, 95% CI: 1.07-5.47, p=0.03). Conclusion: This study showed that the CAPRA-S score, which is effective in predicting the risk of biochemical recurrence after RP, was not effective in predicting the time of biochemical recurrence after RP. Keywords: Biochemical recurrence, CAPRA-S score, prostate cancer, radical prostatectomy